Scott Fidel
Stock Analyst at Stephens & Co.
(2.72)
# 1,903
Out of 4,843 analysts
184
Total ratings
80%
Success rate
13.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners | Reiterates: Overweight | $21 | $14.48 | +45.03% | 5 | May 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $110.78 | +28.18% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $28.71 | +32.36% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $94.07 | +7.37% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $190.35 | +17.15% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $15.37 | +10.61% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $56.44 | +29.34% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $301.91 | +123.58% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $9.92 | +212.50% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $316.64 | +29.48% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $147.26 | +13.40% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $21.17 | -0.80% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $233.13 | +7.24% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $383.84 | +60.22% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $120.90 | -13.15% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $305.04 | +4.90% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $168.77 | -27.71% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $22.64 | +306.36% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $381.39 | -26.58% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $1.12 | +8,382.14% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $5.35 | -71.96% | 3 | Nov 11, 2022 |
Ardent Health Partners
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $14.48
Upside: +45.03%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $110.78
Upside: +28.18%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $28.71
Upside: +32.36%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $94.07
Upside: +7.37%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $190.35
Upside: +17.15%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $15.37
Upside: +10.61%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $56.44
Upside: +29.34%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $301.91
Upside: +123.58%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $9.92
Upside: +212.50%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $316.64
Upside: +29.48%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $147.26
Upside: +13.40%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $21.17
Upside: -0.80%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $233.13
Upside: +7.24%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $383.84
Upside: +60.22%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $120.90
Upside: -13.15%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $305.04
Upside: +4.90%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $168.77
Upside: -27.71%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $22.64
Upside: +306.36%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $381.39
Upside: -26.58%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $1.12
Upside: +8,382.14%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $5.35
Upside: -71.96%